Inventor · disambiguated record
Lisa A. Hasvold
Also filed as: HASVOLD LISA · HASVOLD LISA A · HASVOLD LISA ANNE
33 granted patents·35 pending applications·553 citations·filing 1996–2025
97Inventor score
Top patents by PatentIndex Score
68 records- 0198US8546399B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2010·Granted Oct 1, 2013·100 cites·24 claims
- 0297US9174982B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Nov 3, 2015·38 cites·7 claims
- 0397US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0497US8580794B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Nov 12, 2013·44 cites·3 claims
- 0597US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0696US9034875B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 19, 2015·19 cites·1 claims
- 0794US9315488B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2015·Granted Apr 19, 2016·13 cites·2 claims
- 0894US9073855B2BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·2 claims
- 0994US9045420B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jun 2, 2015·11 cites·1 claims
- 1092US8232273B2Heterocyclic compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2009·Granted Jul 31, 2012·28 cites·31 claims
- 1192US5703244AProcess for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compoundsABBOTT LAB·Filed 1996·Granted Dec 30, 1997·53 cites·8 claims
- 1291US9303025B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Apr 5, 2016·11 cites·4 claims
- 1390US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 1490US7456169B2Heterocyclic kinase inhibitorsABBOTT LAB·Filed 2006·Granted Nov 25, 2008·9 cites·2 claims
- 1589US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 1688US8980879B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Mar 17, 2015·11 cites·32 claims
- 1788US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 1887US10633379B2Bromodomain inhibitorsABBVIE INC·Filed 2017·Granted Apr 28, 2020·4 cites·2 claims
- 1987US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 2087US8148384B2Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeuticsPENNING THOMAS D·Filed 2007·Granted Apr 3, 2012·6 cites·8 claims
- 2186US2025019364A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2024·Application pending·0 cites
- 2283US2024360124A1Bromodomain InhibitorsABBVIE INC·Filed 2023·Application pending·0 cites
- 2383US2024043404A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2023·Application pending·0 cites
- 2482US11897864B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2022·Granted Feb 13, 2024·0 cites·27 claims
- 2580US9050346B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 9, 2015·5 cites·20 claims
- 2680US8445679B27-substituted indole MCL-1 inhibitorsWANG XILU·Filed 2008·Granted May 21, 2013·7 cites·4 claims
- 2780US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 2879US9957263B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted May 1, 2018·3 cites·5 claims
- 2979US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 3078US10035800B2Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jul 31, 2018·3 cites·48 claims
- 3177US9321764B2Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2014·Granted Apr 26, 2016·3 cites·25 claims
- 3276US9493411B2Pyrrole-3-carboxamide bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 15, 2016·3 cites·12 claims
- 3376US9035047B27-substituted indole Mcl-1 inhibitorsABBVIE INC·Filed 2013·Granted May 19, 2015·1 cites·4 claims
- 3475US10131657B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 20, 2018·2 cites·14 claims
- 3575US2022315555A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2021·Application pending·0 cites
- 3675US2021221789A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2020·Application pending·0 cites
- 3773US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 3872US9359296B27-substituted indole Mcl-1 inhibitorsABBVIE INC·Filed 2015·Granted Jun 7, 2016·1 cites·2 claims
- 3972US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 4070US9776990B2Isoindolone derivativesABBVIE INC·Filed 2013·Granted Oct 3, 2017·1 cites·10 claims
- 4170US2020231566A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 4270US2021070756A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 4370US2022017511A1Bromodomain InhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 4469US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 4568US2020291027A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 4668US2019119247A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2018·Application pending·0 cites
- 4767US2020255426A1Bromodomain InhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 4865US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 4963US2019389861A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 5063US2017158666A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →